institutional investment

Kintayl Capital establishes major $10.5M position in Qorvo with 124,268 shares, betting on RF semiconductor recovery through automotive, defense, and connectivity diversification.

Solas Capital acquires $7.53M stake in Primo Brands, signaling confidence in water giant's 29% sales growth and 27% year-to-date stock appreciation.

Solas Capital acquired $5.59M stake in Euronet Worldwide as stock declined 30% YoY, despite company reporting $4.24B revenue and projecting 10-15% earnings growth.

Parkman Healthcare Partners invests $20M in EyePoint Pharmaceuticals as shares surge 93% annually ahead of mid-2026 Phase 3 data for retinal disease treatment DURAVYU.

Waystar's stock fell 32% over a year, but Blue Door Asset Management bought $11.49M in shares, betting on the healthcare software company's strong fundamentals: 17% revenue and 21% EBITDA growth.

Deerfield Management increases Vera Therapeutics stake to $205.58M as kidney drug atacicept approaches July 7 FDA decision. Stock up 50% annually.

Deerfield Management increased its Celcuity stake by $80.6M in Q4, bringing total position to $170.95M. Stock surged 1,040% amid FDA review of breast cancer drug gedatolisib.

Deerfield Management boosts $PRAX stake to $266M as biotech stock surges 685% annually. Company eyes $20B+ pipeline revenue potential with two FDA applications pending.

$PRAX surges 685% annually, securing $80.5M from Driehaus Capital. Two FDA applications pending for neurological therapies with potential $20B+ revenue.

Engineers Gate builds $85.16M Agree Realty stake, adding 1.1M shares. ADC stock surged 13.4% annually, outpacing S&P 500.

Legence surges 80% since IPO as Engle Capital makes $24M bet. Record $708M quarterly revenue, $3.1B backlog fuel investor confidence.

Aperture Investors' $25.59M stake in Ormat Technologies signals confidence as the geothermal company soars 54% annually on strong revenue growth and energy storage expansion.

Condire Management aggressively increases Endeavour Silver stake to 4.5M shares worth $42.3M, signaling conviction in silver producer amid 141.4% annual gains.

Bausch + Lomb posted $5.1B in annual revenue with 6% growth as Caspian Capital builds major stake, signaling institutional confidence.

Clifford Capital Partners acquires $14.2M stake in WEX as fintech reports record $2.66B revenue and $304.1M profit, yet stock remains flat versus S&P 500's 20% gain.

Lodge Hill Capital builds significant $35M position in H&R Block despite 40% stock decline, signaling confidence in tax preparation giant's fundamentals.

Angelo Gordon invested $31.6M in Quanex Building Products amid quarterly losses, with the stock surging 15% year-to-date, signaling contrarian conviction on housing recovery.

Hunting Hill Global Capital liquidated its $23.42M Ethereum Trust position but retained Bitcoin and Coinbase holdings, signaling strategic reallocation rather than crypto sector exit.

Orion Resource Partners invested $2.88 million in Methanex, with the methanol producer's stock surging 45% annually amid firmer pricing and geopolitical headwinds.

General Tensor closes $5M funding to build Bittensor infrastructure, generating TAO tokens 40x more efficiently than competitors.